Low vitamin D status and long-term risk of incident fibromyalgia: a propensity score–matched cohort study
Frontiers in Nutrition · 24.08.2026 · 13
DOI: 10.3389/fnut.2026.1889243 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Nutrition, online erschienen am 24.08.2026. Verfasst von Kuo-Chuan Hung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cross-sectional studies have reported lower serum vitamin D concentrations in patients with fibromyalgia, but whether vitamin D deficiency (VDD) precedes fibromyalgia onset remains uncertain. We conducted a large retrospective cohort study to evaluate the association between VDD and the long-term risk of incident fibromyalgia.
Methods
Within the TriNetX Network, we identified adults (≥18 years of age) whose serum 25-hydroxyvitamin D was below 20 ng/mL and paired them 1:1 with controls having levels ≥30 ng/mL through propensity score matching. A 1-year landmark period was applied to reduce reverse causation, and outcomes were assessed within an analytic window of up to 10 years. The primary outcome was incident fibromyalgia. The secondary outcome was chronic pain–related diagnoses. All-cause mortality was examined separately as a contextual outcome reflecting overall prognostic burden and the competing risk of death. Sensitivity, sex- and age-stratified subgroup, and severity and chronicity analyses were performed, including severe deficiency defined as 25(OH)D < 10 ng/mL and chronic deficiency defined as two serum 25-hydroxyvitamin D measurements <20 ng/mL recorded within 1 year.
Results
After matching, 561,418 patients were included in both cohorts. VDD conferred an elevated risk of incident fibromyalgia (hazard ratio [HR], 1.63; 95% confidence interval [CI], 1.56–1.71; p < 0.001) and chronic pain–related diagnosis (HR, 1.30; 95% CI, 1.28–1.31; p < 0.001). All-cause mortality was also higher in the VDD cohort. The association with fibromyalgia was consistent across sensitivity models (HR, 1.35–1.55; all p < 0.001), present in both sexes, and stronger among adults > 65 years (HR, 1.76; p for subgroup difference <0.001). The severity and chronicity analyses also showed associations with incident fibromyalgia under the severe deficiency definition (HR, 1.89; p < 0.001) and the chronic deficiency definition (HR, 1.97; p < 0.001).
Conclusion
Low vitamin D status was associated with a higher long-term risk of incident fibromyalgia, with associations also observed under the severe and chronic deficiency definitions. Further prospective studies with repeated vitamin D assessments, detailed pain phenotyping, and mechanistic biomarkers are needed to clarify the clinical and biological relevance of this association.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
- Department of Anesthesiology, Chi Mei Hospital, Liouying, Tainan, Taiwan.
Zitieren
APA
Hung, K. C., Chang, L. C., Wang, K. F., & Chen, I. W. (2026). Low vitamin D status and long-term risk of incident fibromyalgia: a propensity score–matched cohort study. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1889243
Vancouver
Hung KC, Chang LC, Wang KF, Chen IW. Low vitamin D status and long-term risk of incident fibromyalgia: a propensity score–matched cohort study. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1889243
BibTeX
@article{Hung2026,
author = {Hung, Kuo-Chuan and Chang, Li-Chen and Wang, Kuei-Fen and Chen, I-Wen},
title = {Low vitamin D status and long-term risk of incident fibromyalgia: a propensity score–matched cohort study},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1889243}
}
EUVIMED